Skip to main content
OpenTrials

Clinical trial condition

Liver Cirrhosis, Biliary

Explore clinical trials studying Liver Cirrhosis, Biliary. Study availability and eligibility vary by location and protocol.

147 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Liver Cirrhosis, Biliary trial results

Not Yet Recruiting

LEOPARD Prospective Validation Cohort 1

NCT06723275

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +14 more
Locations
  • Department of Gastroenterology and Hepatology Universitair Ziekenhuis Gent Ghent, Belgium
  • Hospital Henri Mondor, Department of Hepatology Créteil, France
  • Universitätsklinikum Schleswig - Holstein | UKSH · Transplantation Medicine Kiel, Germany
  • Italian National Transplant Center Roma, Italy
View Trial Details
Completed

Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC

NCT05239468

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Southern California Gastrointestinal (GI) and Liver Centers (SCLC) - Coronado Coronado, California, United States
  • Facey Medical Group Mission Hills, California, United States
  • Schiff Center for Liver Diseases / University of Miami Miami, Florida, United States
View all 26 locations
View Trial Details
Completed

A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

NCT06383403

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Southern California Research Center Coronado, California, United States
  • Topgraphy Health, Inc. Los Angeles, California, United States
  • University of California, Davis Sacramento, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 60 locations
View Trial Details
Completed

Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)

NCT06060665

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The Institute for Liver Health II LLC dba Arizona Clinical Trials; Arizona Liver Health Chandler, Arizona, United States
  • California Liver Research Institute Pasadena, California, United States
  • University of California (UC) Davis Medical Center Sacramento, California, United States
  • California Pacific Medical Center San Francisco, California, United States
View all 45 locations
View Trial Details
Completed

An Open-Label Study Following Oral Dosing of Seladelpar to Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

NCT04950764

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +11 more
Locations
  • Arizona Liver Health Chandler, Arizona, United States
  • University of California Davis Sacramento, California, United States
  • University of Colorado Anschutz Aurora, Colorado, United States
  • Mercy Medical Center Baltimore, Maryland, United States
View all 20 locations
View Trial Details

Related conditions